Bleeding disorder due to P2Y12 defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:36355OMIM:609821D69.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Bleeding disorder due to P2Y12 defect is a rare inherited condition that affects how platelets work in the blood. Platelets are tiny blood cells that help your body stop bleeding by clumping together to form a clot. In this condition, a protein on the surface of platelets called P2Y12 does not work properly. This protein normally acts like a receiver that picks up a signal from a chemical called ADP, which tells platelets to stick together. When P2Y12 is faulty, platelets cannot respond to this signal correctly, so they do not clump together as well as they should. Because of this, people with this condition tend to bleed longer than normal after cuts, injuries, or surgery. The most common symptoms include easy bruising, nosebleeds that are hard to stop, heavy menstrual periods in women, and prolonged bleeding after dental work or operations. The condition is sometimes called P2Y12 receptor defect or ADP receptor defect. Treatment focuses on managing bleeding episodes rather than curing the underlying problem. Doctors may use medications like desmopressin (DDAVP) or platelet transfusions before surgery or during serious bleeding events. Most people with this condition can live a relatively normal life with careful planning and medical support.

Also known as:

Key symptoms:

Easy bruisingNosebleeds that last a long time or are hard to stopHeavy or prolonged menstrual bleeding in womenBleeding that takes longer than normal to stop after cutsProlonged bleeding after dental procedures or tooth extractionsExcessive bleeding after surgeryBleeding into joints or muscles in more severe casesBleeding from the gums

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Bleeding disorder due to P2Y12 defect.

View clinical trials →

No actively recruiting trials found for Bleeding disorder due to P2Y12 defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Bleeding disorder due to P2Y12 defect community →

No specialists are currently listed for Bleeding disorder due to P2Y12 defect.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Bleeding disorder due to P2Y12 defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Bleeding disorder due to P2Y12 defectForum →

No community posts yet. Be the first to share your experience with Bleeding disorder due to P2Y12 defect.

Start the conversation →

Latest news about Bleeding disorder due to P2Y12 defect

1 articles
AdvocacyRSSApr 22, 2026
For World Hemophilia Day, focus is on early, accurate diagnosis
World Hemophilia Day on April 17 is highlighting the importance of getting diagnosed early and accurately for hemophilia and other bleeding disorders. Early dia
See all news about Bleeding disorder due to P2Y12 defect

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What platelet function tests do I need, and how often should they be repeated?,What should I do before any surgery or dental procedure to reduce my bleeding risk?,Which medications should I completely avoid because of my condition?,Should my family members be tested for this condition?,What should I do if I have a serious bleeding episode at home or away from a hospital?,Are there any clinical trials or new treatments I should know about?,How will this condition affect pregnancy or childbirth if I plan to have children?

Common questions about Bleeding disorder due to P2Y12 defect

What is Bleeding disorder due to P2Y12 defect?

Bleeding disorder due to P2Y12 defect is a rare inherited condition that affects how platelets work in the blood. Platelets are tiny blood cells that help your body stop bleeding by clumping together to form a clot. In this condition, a protein on the surface of platelets called P2Y12 does not work properly. This protein normally acts like a receiver that picks up a signal from a chemical called ADP, which tells platelets to stick together. When P2Y12 is faulty, platelets cannot respond to this signal correctly, so they do not clump together as well as they should. Because of this, people wit

How is Bleeding disorder due to P2Y12 defect inherited?

Bleeding disorder due to P2Y12 defect follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.